Zelminemab (AMG-301) is a humanized monoclonal antibody targeting the pituitary adenylate cyclase-activating polypeptide type I receptor (ADCYAP1R1) for use in neurological disorders.
Purity:
95.00%
CAS Number:
[2225850-33-7]
Target:
Adenylate cyclase
* VAT and and shipping costs not included. Errors and price changes excepted